Trident Texofab Ltd

For the second consecutive session, Trident Texofab Ltd has seen its share price slide further, hitting a fresh 52-week low of Rs 23.41 on 6 Aug 2026. This decline extends a painful downtrend that has wiped out nearly 90% of the stock’s value over the past year, sharply contrasting with the broader market’s modest losses.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 06 August 2026, providing investors with the latest insights into its performance and outlook.

Trident Texofab Ltd’s share price declined sharply to hit a new 52-week low of Rs.24.64 on 5 August 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The stock underperformed its sector and broader market indices despite a positive opening, reflecting persistent pressures on the company’s financial and market performance.

For the tenth consecutive session, Trident Texofab Ltd has closed lower, culminating in a fresh 52-week low of Rs 25.47 on 3 Aug 2026. This marks a steep decline of 24.17% over this period, underscoring persistent selling pressure despite broader market resilience.

Trident Texofab Ltd’s stock price declined to a fresh 52-week low of Rs.25.59 on 31 July 2026, marking a significant milestone in its ongoing downward trajectory. The stock has experienced a sustained fall over the past several weeks, reflecting a combination of financial pressures and market dynamics within the garments and apparels sector.

Despite broader market resilience, Trident Texofab Ltd has plunged to a fresh 52-week low of Rs 27.38 on 30 Jul 2026, marking a steep 87.21% decline over the past year and underscoring persistent headwinds for this micro-cap garment and apparel player.

Trident Texofab Ltd’s stock price declined to a fresh 52-week low of Rs.28.42 on 29 Jul 2026, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent pressures on the company’s financial and market performance.

Trident Texofab Ltd’s stock price declined to a fresh 52-week low of Rs.29.99 on 28 July 2026, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in both its financial performance and market sentiment.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 22 July 2026, providing investors with an up-to-date view of the stock’s fundamentals, returns, and technical outlook.

While the Sensex surged 1.25% to 78,151.45 on 17 Jul 2026, Trident Texofab Ltd plunged to a fresh 52-week low of Rs 30, marking a steep 84.63% decline over the past year and underscoring a stark divergence from broader market gains.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics discussed here reflect the company’s current position as of 10 July 2026, providing investors with the latest insights into its performance and outlook.

For the sixth straight session, Trident Texofab Ltd closed lower, breaching its 52-week low at Rs 30.36 on 09 Jul 2026. This marks a steep decline of 17.9% over the past six days, underscoring sustained selling pressure despite a broadly positive market backdrop.

Trident Texofab Ltd’s stock price declined to a fresh 52-week low of Rs.32.1 on 8 July 2026, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in both its financial performance and market sentiment.

For the fifth straight session, Trident Texofab Ltd closed lower, breaching its 52-week low at Rs 32.12 on 7 Jul 2026, marking a steep decline of over 85% from its peak of Rs 379 in the past year.

Trident Texofab Ltd’s stock price declined to a fresh 52-week low of Rs.33.55 on 6 July 2026, marking a significant milestone in its ongoing downward trajectory. The stock has underperformed its sector and broader market indices, reflecting persistent challenges in financial performance and valuation metrics.

While the broader market indices showed resilience with the Sensex gaining 0.63% today, Trident Texofab Ltd continued its downward spiral, hitting a fresh 52-week low of Rs 34.19 on 3 Jul 2026. This decline extends the stock’s year-long slide, which now stands at a steep -83.86%, far outpacing the Sensex’s modest -6.30% loss over the same period.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 29 June 2026, providing investors with the latest insights into its performance and outlook.

Trident Texofab Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 01 June 2026. However, the analysis and financial metrics presented here reflect the company’s current position as of 17 June 2026, providing investors with the latest insights into its performance and outlook.